Top compounds associated with response to UEVLD


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA I-BET-762 GDSC1000 pan-cancer AAC -0.13 2e-05
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.14 2e-05
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA tivantinib CTRPv2 pan-cancer AAC -0.22 2e-05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA BMS-345541 CTRPv2 pan-cancer AAC -0.18 3e-05
Download CSV